Cargando…
History and current state of immunotherapy in glioma and brain metastasis
Malignant brain tumors such as glioblastoma (GBM) and brain metastasis have poor prognosis despite conventional therapies. Successful use of vaccines and checkpoint inhibitors in systemic malignancy has increased the hope that immune therapies could improve survival in patients with brain tumors. Ma...
Autores principales: | McGranahan, Tresa, Li, Gordon, Nagpal, Seema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424864/ https://www.ncbi.nlm.nih.gov/pubmed/28529551 http://dx.doi.org/10.1177/1758834017693750 |
Ejemplares similares
-
Current State of Immunotherapy for Treatment of Glioblastoma
por: McGranahan, Tresa, et al.
Publicado: (2019) -
A Neuro-oncologist’s Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer
por: McGranahan, Tresa, et al.
Publicado: (2017) -
Management of Brain Metastases from Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Cancer
por: McGranahan, Tresa M., et al.
Publicado: (2022) -
58. CLINICAL PRESENTATION AND IMAGING CHARACTERISTICS OF LEPTOMENINGEAL CARCINOMATOSIS (LC) IN PATIENTS WITH EGFR MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)
por: Eastman, Boryana, et al.
Publicado: (2020) -
Urbanization and its implications for food and farming
por: Satterthwaite, David, et al.
Publicado: (2010)